{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:18:58Z","timestamp":1779113938071,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T00:00:00Z","timestamp":1339891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p>Adverse cutaneous reactions are one of the most frequent types of adverse drug reactions, and have been reported with a wide range of psychotropics including typical and atypical antipsychotics. However the majority of adverse cutaneous reactions are relatively minor, and severe reactions are relatively rare. Aripiprazole is a third-generation atypical antipsychotic that has been available in the UK for over seven years. Here the author reports the first reported case of a lichenoid drug reaction to aripiprazole, a severe and potentially life-threatening adverse cutaneous reaction that required medical and surgical intervention.<\/jats:p>","DOI":"10.1177\/2045125312451442","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T20:54:17Z","timestamp":1340052857000},"page":"195-198","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Aripiprazole induced severe and extensive skin reaction: A case report"],"prefix":"10.1177","volume":"2","author":[{"given":"Caroline","family":"Parker","sequence":"first","affiliation":[{"name":"CNWL NHS FT, St Charles Hospital, Exmoor Street, London W10 6DZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,6,17]]},"reference":[{"key":"bibr1-2045125312451442","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006617.pub2"},{"key":"bibr2-2045125312451442","unstructured":"Commission on Human Medicines\/Medicines and Healthcare products Regulatory Agency (2012) Drug Analysis Print. Available at: http:\/\/www.mhra.gov.uk\/home\/groups\/public\/documents\/sentineldocuments\/dap_1330408806495.pdf (accessed 3 March 2012)."},{"key":"bibr3-2045125312451442","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060071"},{"key":"bibr4-2045125312451442","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1010"},{"key":"bibr5-2045125312451442","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04563"},{"key":"bibr6-2045125312451442","unstructured":"Otsuka, Squibb Bristol-Myers (2011) Abilify Orodispersible tablets, Oral solution Summary of Product Characteristics. Available at: http:\/\/www.medicines.org.uk\/EMC\/medicine\/18494\/SPC\/Abilify+Tablets%2c+Orodispersible+Tablets%2c+Oral+Solution+%28Otsuka+%26+Bristol-Myers+Squibb%29\/ (accessed 3 March 2012)."},{"key":"bibr7-2045125312451442","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7140.1295"},{"key":"bibr8-2045125312451442","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000224789.21406.81"},{"key":"bibr9-2045125312451442","first-page":"357","volume":"53","author":"Svensson C.","year":"2000","journal-title":"Pharmacol Rev"},{"key":"bibr10-2045125312451442","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00003"},{"key":"bibr11-2045125312451442","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7143.1511"},{"key":"bibr12-2045125312451442","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203090-00005"},{"key":"bibr13-2045125312451442","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304010-00003"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125312451442","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2045125312451442","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125312451442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:49:11Z","timestamp":1777592951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2045125312451442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,17]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1177\/2045125312451442"],"URL":"https:\/\/doi.org\/10.1177\/2045125312451442","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,17]]}}}